RECRUITINGOBSERVATIONAL
METABolic Deterioration in HTX Determines Outcomes
METAB-HTX: Prospective, Longitudinal Cohort Study Evaluationg Cardiac and Systemic Metabolism After Heart Transplantation
About This Trial
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age: ≥ 18 years
- Planned or already conducted heart transplantation
- willing to sign a consent form
Who Should NOT Join This Trial:
- Absence of willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age: ≥ 18 years
* Planned or already conducted heart transplantation
* Informed consent
Exclusion Criteria:
* Absence of informed consent
Locations (1)
University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology
Düsseldorf, North Rhine-Westphalia, Germany